Showing results (221-230 of 339) with videos related to

Sort By:
Pageof 34
The Pediatric Infectious Disease Journal|October 24, 2002
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control studyJames D Kellner, David W Scheifele, Scott A Halperin, et al.
Vaccine|October 4, 2005
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsScott A Halperin, Simon Dobson, Shelly McNeil, et al.
Vaccine|October 19, 2006
An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccineJoanne M Langley, Gerald Predy, R Guasparini, et al.
Vaccine|December 20, 2011
The changing and dynamic epidemiology of meningococcal diseaseScott A Halperin, Julie A Bettinger, Brian Greenwood, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
Vaccine|June 23, 2009
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunityJason Kindrachuk, Håvard Jenssen, Melissa Elliott, et al.
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
The Pediatric Infectious Disease Journal|December 19, 2013
Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccineScott A Halperin, Bruce Tapiéro, Marc Dionne, et al.
The Pediatric Infectious Disease Journal|October 1, 2011
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in CanadaOtto G Vanderkooi, David W Scheifele, Douglas Girgenti, et al.
Vaccine|May 21, 2013
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodiesMonika Polewicz, Aleksandra Gracia, Srinivas Garlapati, et al.
Pageof 34